GT Biopharma
GTBP
GTBP
18 hedge funds and large institutions have $29.3M invested in GT Biopharma in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
17% less capital invested
Capital invested by funds: $35.3M → $29.3M (-$6M)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$9.96K | |
| 2 | +$8.03K | |
| 3 | +$5.34K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.88K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.33K |